This hypothesis connects disrupted oxytocin systems with high smoking rates in schizophrenia, suggesting new treatment avenues.
Individuals with schizophrenia exhibit extraordinarily high rates of smoking (60-90%) and substance use disorders (42% lifetime prevalence), yet the neurobiological mechanisms underlying this comorbidity remain incompletely understood. This paper proposes that oxytocin system dysregulation serves as a unifying mechanism connecting psychotic disorders with addiction vulnerability. Drawing on converging evidence from human studies and animal models, the hypothesis integrates with the broader Oxytocin-Dopamine Convergence Model and generates specific, testable predictions for understanding and preventing substance use in this high-risk population.
No takes yet. Share an insight, caveat, or question.
Jochen Kaufmann (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: